Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Requip PR Extension Study in Parkinson's Disease
NCT01536574Phase 3Completed
- Sponsor
- GSK
- Start
- Sep 2010
- Primary completion
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ropinirole in Parkinson's disease (PD), sponsored by GSK. Started Sep 2010; status: completed.
02
Drugs
ropinirole
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT01536574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01536574.